PetMed Express Earnings Seem Immune to Coronavirus
The coronavirus pandemic has done a number on a number of American retailers -- but PetMed Express (NASDAQ: PETS) is not one of them.
As the name implies, PetMed Express is in the business of selling prescription and non-prescription medicine for pets, and by all indications, business is (mostly) booming. The company's fiscal fourth-quarter 2020 earnings results, released Monday morning, showed sales up a big 15% in Q4, with profits up a more modest 9%.
Image source: Getty Images.
Source Fool.com
